These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 33452629)

  • 1. Therapeutic Advances in Movement Disorders.
    Tanner CM; Ostrem JL
    Neurotherapeutics; 2020 Oct; 17(4):1325-1330. PubMed ID: 33452629
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic deep brain stimulation for movement disorders.
    Caparros-Lefebvre D; Blond S; N'guyen JP; Pollak P; Benabid AL
    Adv Tech Stand Neurosurg; 1999; 25():61-136; discussion 136-8. PubMed ID: 10370717
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical management of spasticity.
    Thompson AJ; Jarrett L; Lockley L; Marsden J; Stevenson VL
    J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):459-63. PubMed ID: 15774425
    [No Abstract]   [Full Text] [Related]  

  • 4. Thalamic stimulation in movement disorders.
    Balasubramaniam V
    J Neurosurg; 1997 Apr; 86(4):737. PubMed ID: 9120645
    [No Abstract]   [Full Text] [Related]  

  • 5. Deep brain stimulation for movement disorders.
    Rosenow JM; Mogilnert AY; Ahmed A; Rezai AR
    Neurol Res; 2004 Jan; 26(1):9-20. PubMed ID: 14977053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immediate versus delayed electrical stimulation boosts botulinum toxin effect: A pilot study.
    Picelli A; Smania N; Storti I; Munari D; Fontana C; Fiaschi A; Santilli V; Tamburin S
    Mov Disord; 2011 Aug; 26(9):1784-5. PubMed ID: 21538521
    [No Abstract]   [Full Text] [Related]  

  • 7. New treatments for movement disorders?
    Fox SH; Brotchie JM
    Trends Pharmacol Sci; 1996 Oct; 17(10):339-42. PubMed ID: 8979766
    [No Abstract]   [Full Text] [Related]  

  • 8. Thalamic stimulation for control of movement disorders.
    Andy OJ
    Appl Neurophysiol; 1983; 46(1-4):107-11. PubMed ID: 6608315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coding for the use of botulinum toxin for movement disorders.
    Brashear A; Bushong L
    Continuum (Minneap Minn); 2013 Oct; 19(5 Movement Disorders):1406-15. PubMed ID: 24092297
    [No Abstract]   [Full Text] [Related]  

  • 10. Mesothalamic brain stimulation for movement disorders (functional ablation of mini-discharge circuits).
    Andy OJ
    Pavlov J Biol Sci; 1987; 22(1):40. PubMed ID: 3494224
    [No Abstract]   [Full Text] [Related]  

  • 11. Chronic stimulation of subthalamic nucleus improves levodopa-induced dyskinesias in Parkinson's disease.
    Krack P; Limousin P; Benabid AL; Pollak P
    Lancet; 1997 Dec; 350(9092):1676. PubMed ID: 9400515
    [No Abstract]   [Full Text] [Related]  

  • 12. [Resistance to treatment in movement disorders].
    Vingerhoets FJ; Burkhard PR
    Rev Med Suisse; 2012 May; 8(339):926-9. PubMed ID: 22675821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Orofacial Movement Disorders.
    Clark GT; Ram S
    Oral Maxillofac Surg Clin North Am; 2016 Aug; 28(3):397-407. PubMed ID: 27475514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic extradural cortical stimulation for movement disorders: a review.
    Canavero S; Bonicalzi V; Paolotti R; Castellano G; Greco-Crasto S; Rizzo L; Davini O; Maina R
    Neurol Res; 2003 Mar; 25(2):118-22. PubMed ID: 12635508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional brain imaging of movement disorders.
    Eidelberg D; Edwards C
    Neurol Res; 2000 Apr; 22(3):305-12. PubMed ID: 10769825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Movement Disorders and Voice.
    Snow G; Guardiani E
    Otolaryngol Clin North Am; 2019 Aug; 52(4):759-767. PubMed ID: 31076164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical application of transcutaneous electrical nerve stimulation and high cervical cord stimulation for movement disorders.
    Lamb S
    J Neurosurg Nurs; 1983 Feb; 15(1):1-4. PubMed ID: 6601695
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanisms and the current state of deep brain stimulation in neuropsychiatry.
    Greenberg BD; Rezai AR
    CNS Spectr; 2003 Jul; 8(7):522-6. PubMed ID: 12894033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Introduction: the importance of cognition in movement disorders.
    Burn D; Weintraub D; Robbins T
    Mov Disord; 2014 Apr; 29(5):581-3. PubMed ID: 24757107
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic use of type F botulinum toxin.
    Ludlow CL; Hallett M; Rhew K; Cole R; Shimizu T; Sakaguchi G; Bagley JA; Schulz GM; Yin SG; Koda J
    N Engl J Med; 1992 Jan; 326(5):349-50. PubMed ID: 1728750
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.